TRAW — TRAWS PHARMA INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 35 SEC-registered investment managers reported holding TRAW (TRAWS PHARMA INC) in their latest 13F filings, with a combined reported value of $5.26M across 6.24M shares. That is +50.4% by share count (+1.51M shares) versus the previous quarter, while reported value moved -30.7%. Ownership is concentrated: the five largest holders account for 62.1% of reported value and the top ten for 87.5%.
Compared with the prior quarter, 15 opened new positions, 9 added to existing stakes, 7 trimmed, 7 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of TRAWS PHARMA INC (TRAW) include ORBIMED ADVISORS LLC, PERCEPTIVE ADVISORS LLC, Squadron Capital Management LLC, ranked by reported 13F value among the 77 institutional holders on this page.
TRAW is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 18 | 471.34K | $277.88K | -47.2% |
| Q2 2026 | 35 | 6.24M | $5.26M | +50.4% |
| Q1 2026 | 27 | 3.62M | $6.62M | -5.9% |
| Q4 2025 | 22 | 3.42M | $3.86M | +96.5% |
| Q3 2025 | 18 | 1.30M | $2.41M | +7.4% |
| Q2 2025 | 19 | 1.26M | $1.87M | -3.3% |
| Q1 2025 | 21 | 1.75M | $4.01M | +21.0% |
| Q4 2024 | 20 | 1.18M | $10.34M | +0.1% |
Over the 8 quarters shown, institutional share counts decreased 60% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2025 (+96.5%).
Top Institutional Holders (Q3 2026) — 18 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 152.85K | $90.79K | 0.00% | Reduce | |
| 110.97K | $65.89K | 0.00% | Hold | |
| 54.51K | $32.38K | 0.00% | Hold | |
| 50.10K | $29.00K | 0.00% | Reduce | |
| 25.80K | $15.32K | 0.00% | Hold | |
| 19.62K | $11.65K | 0.00% | Add | |
| 19.09K | $11.33K | 0.00% | Reduce | |
| 11.76K | $6.98K | 0.00% | New | |
| 11.11K | $5.30K | 0.00% | New | |
| 8.02K | $4.76K | 0.00% | Reduce | |
| 4.67K | $2.78K | 0.00% | Hold | |
| 1.72K | $1.02K | 0.00% | Hold | |
| 837 | $497 | 0.00% | Add | |
| 262 | $156 | 0.00% | Hold | |
| 10 | $6 | 0.00% | Add | |
| 5 | $3 | 0.00% | New | |
| 2 | $1 | 0.00% | Hold | |
| 2 | $1 | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.20M | $1.01M | 0.02% | Add | |
| 786.24K | $663.03K | 0.59% | New | |
| 730.00K | $615.61K | 0.00% | Hold | |
| 597.73K | $504.06K | 0.03% | Add | |
| 559.47K | $471.80K | 0.06% | Add | |
| 478.14K | $403.22K | 0.07% | Reduce | |
| 398.49K | $336.04K | 0.05% | New | |
| 330.05K | $278.23K | 0.00% | Add | |
| 216.01K | $182.16K | 0.00% | Add | |
| 164.38K | $138.62K | 0.00% | New | |
| 133.94K | $112.95K | 0.00% | Reduce | |
| 111.36K | $93.92K | 0.00% | New | |
| 111.36K | $93.92K | 0.00% | Add | |
| 91.22K | $76.00K | 0.00% | New | |
| 84.40K | $71.17K | 0.00% | New | |
| 80.57K | $67.95K | 0.05% | Reduce | |
| 54.51K | $45.95K | 0.00% | Add | |
| 37.45K | $31.59K | 0.00% | New | |
| 18.09K | $15.26K | 0.00% | New | |
| 14.52K | $12.00K | 0.00% | New | |
| 12.58K | $11.00K | 0.00% | New | |
| 9.94K | $8.38K | 0.00% | Hold | |
| 5.14K | $4.34K | 0.00% | Add | |
| 4.68K | $3.94K | 0.00% | New | |
| 3.45K | $2.91K | 0.00% | Reduce |
Q1 2026 — 25 funds
Q4 2025 — 22 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 730.00K | $824.90K | 0.00% | Add | |
| 713.54K | $806.30K | 0.34% | New | |
| 678.14K | $766.30K | 0.09% | Add | |
| 605.53K | $684.25K | 0.01% | Hold | |
| 194.54K | $219.83K | 0.01% | New | |
| 154.43K | $174.51K | 0.01% | New | |
| 87.26K | $98.60K | 0.00% | Hold | |
| 61.65K | $69.67K | 0.00% | Add | |
| 49.26K | $55.66K | 0.04% | New | |
| 42.21K | $47.70K | 0.00% | Add | |
| 25.80K | $29.16K | 0.00% | New | |
| 24.82K | $28.05K | 0.00% | New | |
| 19.24K | $21.75K | 0.00% | Reduce | |
| 14.20K | $16.04K | 0.00% | New | |
| 9.96K | $11.25K | 0.00% | Hold | |
| 7.72K | $8.73K | 0.00% | Add | |
| 162 | $183 | 0.00% | Hold | |
| 113 | $128 | 0.00% | Add | |
| 8 | $9 | 0.00% | New | |
| 5 | $5 | 0.00% | New | |
| 2 | $2 | 0.00% | Hold | |
| 1 | $1 | 0.00% | Reduce |
Q3 2025 — 18 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 605.53K | $1.12M | 0.03% | Hold | |
| 330.00K | $610.50K | 0.00% | Hold | |
| 150.00K | $277.50K | 0.01% | Hold | |
| 87.26K | $161.43K | 0.00% | Add | |
| 43.44K | $80.37K | 0.00% | Add | |
| 28.49K | $52.71K | 0.01% | Hold | |
| 22.02K | $40.73K | 0.00% | Add | |
| 12.57K | $23.00K | 0.00% | New | |
| 10.71K | $19.81K | 0.00% | New | |
| 9.96K | $18.42K | 0.00% | Hold | |
| 3.53K | $6.53K | 0.00% | Add | |
| 719 | $1.33K | 0.00% | Hold | |
| 162 | $300 | 0.00% | Hold | |
| 102 | $189 | 0.00% | Add | |
| 96 | $178 | 0.00% | Hold | |
| 6 | $11 | 0.00% | Reduce | |
| 2 | $4 | 0.00% | New | |
| 2 | $4 | 0.00% | Hold |
Q2 2025 — 19 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 605.53K | $896.19K | 0.02% | Hold | |
| 330.00K | $488.40K | 0.00% | Hold | |
| 149.80K | $221.70K | 0.01% | Reduce | |
| 52.63K | $77.89K | 0.00% | Hold | |
| 35.73K | $52.87K | 0.00% | Add | |
| 28.49K | $42.17K | 0.01% | Hold | |
| 17.17K | $25.41K | 0.00% | New | |
| 16.06K | $23.77K | 0.00% | New | |
| 13.17K | $19.50K | 0.00% | Hold | |
| 9.96K | $14.73K | 0.00% | Hold | |
| 3.01K | $4.45K | 0.00% | Reduce | |
| 719 | $1.06K | 0.00% | Reduce | |
| 706 | $1.04K | 0.00% | Reduce | |
| 162 | $240 | 0.00% | Reduce | |
| 102 | $151 | 0.00% | New | |
| 96 | $142 | 0.00% | Reduce | |
| 94 | $139 | 0.00% | Add | |
| 60 | $89 | 0.00% | New | |
| 2 | $3 | 0.00% | Hold |
New Positions (Q2 2026)
- Ally Bridge Group (NY) LLC 786.24K sh · $663.03K
- SPHERA FUNDS MANAGEMENT LTD. 398.49K sh · $336.04K
- Alyeska Investment Group, L.P. 164.38K sh · $138.62K
- GEODE CAPITAL MANAGEMENT, LLC 111.36K sh · $93.92K
- HRT FINANCIAL LP 91.22K sh · $76.00K
- Kynam Capital Management, LP 84.40K sh · $71.17K
- Northern Trust Corp 37.45K sh · $31.59K
- XTX Topco Ltd 18.09K sh · $15.26K
- SG Americas Securities, LLC 14.52K sh · $12.00K
- Virtu Financial LLC 12.58K sh · $11.00K
- HUNTINGTON NATIONAL BANK 4.68K sh · $3.94K
- BARCLAYS PLC 1.95K sh · $1.64K
Fully Exited (vs previous quarter)
- Squadron Capital Management LLC sold 511.71K sh · $936.44K
- Palumbo Wealth Management LLC sold 61.17K sh · $111.95K
- STATE STREET CORP sold 25.80K sh · $47.22K
- Two Sigma Investments sold 19.24K sh · $35.22K
- Robinswood Financial LLC sold 5 sh · $9
- Caitong International Asset Management Co., Ltd sold 2 sh · $4
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO sold 2 sh · $4
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 152.85K | 330.05K | 55.19K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 110.97K | 111.36K | 77.10K | 61.65K | 43.44K | 35.73K | 33.38K | 20.80K | — | 224.09K | 192.86K | 192.86K | 192.86K | 169.50K | 169.50K | 169.50K | 169.85K | 169.85K | 162.97K | 162.97K |
| VANGUARD FIDUCIARY TRUST CO | 54.51K | 54.51K | 31.80K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| HRT FINANCIAL LP | 50.10K | 91.22K | — | — | 12.57K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 25.80K | — | 25.80K | 25.80K | — | — | — | — | — | 60.09K | 52.79K | 52.79K | 52.79K | — | — | — | — | — | — | — |
| UBS Group AG | 19.62K | 3.45K | 4.05K | 7.72K | 6 | 3.01K | 14.32K | 791 | 630 | 98.58K | 263 | 7.66K | 63 | 5.66K | 14.60K | 14.47K | 23.50K | 300 | 4.12K | 2.43K |
| JANE STREET GROUP, LLC | 19.09K | 216.01K | 21.24K | — | — | — | — | — | — | 25.06K | — | — | — | — | — | — | — | — | — | — |
| Citigroup Inc | 11.76K | — | — | 1 | 3.53K | 60 | — | — | — | — | — | — | — | — | — | — | — | 135 | — | — |
| StoneX Group Inc. | 11.11K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BlackRock Inc | 8.02K | 9.94K | 9.96K | 9.96K | 9.96K | 9.96K | 9.96K | 9.96K | 9.96K | — | — | — | — | — | — | — | — | — | — | — |
| HUNTINGTON NATIONAL BANK | 4.67K | 4.68K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SBI Securities Co., Ltd. | 1.72K | 1.72K | 128 | 162 | 162 | 162 | 507 | 155 | — | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 837 | 468 | 3.73K | — | 719 | 719 | 725 | 15.72K | 729 | 18.25K | 18.86K | 18.86K | 20.11K | 20.11K | 10.86K | 10.86K | 10.86K | 15.86K | 16.96K | 16.30K |
| Vanguard Global Advisers, LLC | 262 | 262 | 262 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| HARBOUR INVESTMENTS, INC. | 10 | 5 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 5 | — | 2 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 2 | 2 | 23 | 2 | 2 | 2 | 2 | — | — | — | 1.00K | — | — | 3 | 1 | — | — | — | — | — |
| JONES FINANCIAL COMPANIES LLLP | 2 | 2 | 2 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ORBIMED ADVISORS LLC | — | 1.20M | 605.53K | 605.53K | 605.53K | 605.53K | 605.53K | 605.53K | 605.53K | 1.05M | — | — | — | — | — | — | — | — | — | — |
| PERCEPTIVE ADVISORS LLC | — | — | — | — | — | — | 421.78K | 164.16K | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold TRAW?
As of 2026-Q2, 35 institutional funds reported holding TRAW (TRAWS PHARMA INC) in SEC 13F filings, with a combined reported value of $5.26M.
How many shares of TRAW do institutions own?
13F filers reported 6.24M shares of TRAW, worth $5.26M in aggregate at the end of 2026-Q2.
Is institutional ownership of TRAW rising or falling?
Share counts moved +50.4% versus the prior quarter — accumulation.
Who are the top institutional holders of TRAW?
The largest 13F holders are ORBIMED ADVISORS LLC, PERCEPTIVE ADVISORS LLC, Squadron Capital Management LLC, Ally Bridge Group (NY) LLC, ADAGE CAPITAL PARTNERS GP, L.L.C.; the top 25 are ranked at the top of this page.
Who are the major shareholders of TRAWS PHARMA INC?
The major shareholders of TRAWS PHARMA INC (TRAW) by reported 13F value are ORBIMED ADVISORS LLC, PERCEPTIVE ADVISORS LLC, Squadron Capital Management LLC, Ally Bridge Group (NY) LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., among 77 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.